Balancing Surgical Innovation with Indications: A Multicenter Retrospective Comparison of Reduced-Port Distal Gastrectomy Using da Vinci SP Versus Multi-Port Robotic Platforms from the KLASS-13 Cohort
Cancers · 04.03.2026 · 18 (5) · 823
DOI: 10.3390/cancers18050823 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 04.03.2026. Verfasst von Jae Hun Chung und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Pusan National University Yangsan Hospital, School of Medicine, Pusan National University, Yangsan 50612, Republic of Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academic Research Support Project of Korea University.
Abstract (Originalsprache)
Background
The da Vinci single-port reduced-port robotic distal gastrectomy (spRRDG) approach shows promise in enhancing surgical recovery while maintaining oncologic safety, but robust multicenter comparative data across diverse robotic platforms are lacking. We aimed to compare clinical outcomes between spRRDG and conventional RRDG (cRRDG) using Korean Laparoendoscopic Gastrointestinal Surgery Study-13 data.
Methods
Clinicopathologic variables and perioperative outcomes concerning 820 patients who underwent curative RRDG with D1+ or D2 lymph node dissection (LND) (da Vinci spRRDG, n = 86; cRRDG, n = 734) were analyzed. We compared continuous variables using Student’s t- or Wilcoxon rank-sum tests, as appropriate, and categorical variables using χ2 or Fisher’s exact tests. Subgroup analyses were performed according to the extent of LND (D1+ vs. D2). Statistical significance was defined as p < 0.05. Results: spRRDG involved a longer operative time than cRRDG (227.06 ± 6.19 vs. 183.58 ± 2.18 min, p < 0.0001) and fewer retrieved LNs (rLNs) (36.38 ± 1.53 vs. 46.52 ± 0.66, p < 0.0001), but showed superior enhanced recovery after surgery (ERAS)-related outcomes, including shorter hospital stay (4.06 ± 0.23 vs. 5.95 ± 0.13 days), and earlier gas passage (postoperative day [POD] 2.24 ± 0.10 vs. 3.08 ± 0.04) and soft diet initiation (POD 1.59 ± 0.14 vs. 2.89 ± 0.07; all p < 0.0001). In subgroup analyses, the number of rLNs was lower in D1+ spRRDG (34.09 ± 1.58 vs. 44.36 ± 0.72, p < 0.0001), but remained above the oncologic threshold (≥16 LNs). In D2 dissections, no significant difference was observed (45.71 ± 3.69 vs. 53.30 ± 1.39, p = 0.1030). Faster postoperative recovery in spRRDG persisted after adjustment. Conclusion: spRRDG exhibited lower rLNs than cRRDG but remained within an oncologically acceptable range. Comparable complication rates and significantly improved ERAS outcomes suggest spRRDG is safe and feasible; however, its clinical application should remain limited to early gastric cancer until robust evidence from prospective studies emerges.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Pusan National University Yangsan Hospital, School of Medicine, Pusan National University, Yangsan 50612, Republic of Korea.
- Department of Surgery, Gastric Cancer Center, Yonsei Cancer Center, Yonsei University College of Medicine, Yonsei University Health System, Seoul 03722, Republic of Korea.
- Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
- Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, Republic of Korea.
- Department of Surgery, Korea University Ansan Hospital, Korea University College of Medicine, Ansan 15355, Republic of Korea.
ORCID-Profile: Hyoung-Il Kim, Sang-Hoon Ahn, Han Hong Lee, Young Suk Park, Chang Min Lee
Förderung
- Academic Research Support Project of Korea University
Zitieren
APA
Chung, J. H., Kim, H. I., Ahn, S. H., Lee, H. H., Suh, Y. S., Kim, Y. M., Park, Y. S., Park, S. H., & Lee, C. M. (2026). Balancing Surgical Innovation with Indications: A Multicenter Retrospective Comparison of Reduced-Port Distal Gastrectomy Using da Vinci SP Versus Multi-Port Robotic Platforms from the KLASS-13 Cohort. Cancers, 18(5), 823. https://doi.org/10.3390/cancers18050823
Vancouver
Chung JH, Kim HI, Ahn SH, Lee HH, Suh YS, Kim YM, et al. Balancing Surgical Innovation with Indications: A Multicenter Retrospective Comparison of Reduced-Port Distal Gastrectomy Using da Vinci SP Versus Multi-Port Robotic Platforms from the KLASS-13 Cohort. Cancers. 2026;18(5):823. doi:10.3390/cancers18050823
BibTeX
@article{Chung2026,
author = {Chung, Jae Hun and Kim, Hyoung-Il and Ahn, Sang-Hoon and Lee, Han Hong and Suh, Yun-Suhk and Kim, Yoo Min and Park, Young Suk and Park, Sung Hyun and Lee, Chang Min},
title = {Balancing Surgical Innovation with Indications: A Multicenter Retrospective Comparison of Reduced-Port Distal Gastrectomy Using da Vinci SP Versus Multi-Port Robotic Platforms from the KLASS-13 Cohort},
journal = {Cancers},
year = {2026},
volume = {18},
number = {5},
pages = {823},
doi = {10.3390/cancers18050823}
}
EUVIMED